Multiple Sclerosis Discovery Forum

Inspiring Connections

Most Viewed Papers

A 3-year Multi-center Study to Describe Changes of OCT Parameters Under Treatment With Gilenya® (PASSOS)
Bilateral Surgical Reconstruction for Internal Jugular Veins Disease in Patients With Chronic Cerebrospinal Venous Insufficiency and associated Multiple Sclerosis.
Optimizing treatment initiation: Effects of a patient education program about fingolimod treatment on knowledge, self-efficacy and patient satisfaction.
The Fc Receptor-Like 3 Polymorphisms (rs7528684, rs945635, rs3761959 and rs2282284) and The Risk of Neuromyelitis Optica in A Chinese Population.
Higher-resolution MR elastography reveals early mechanical signatures of neuroinflammation in patients with clinically isolated syndrome.
Pre- and postsynaptic type-1 cannabinoid receptors control the alterations of glutamate transmission in experimental autoimmune encephalomyelitis.
IM interferon beta-1a delays definite multiple sclerosis 5 years after a first demyelinating event.
Quantification of Global Cerebral Atrophy in Multiple Sclerosis from 3T MRI Using SPM: The Role of Misclassification Errors.
Ethical considerations when counseling patients about stem cell tourism.
Central Neuropathic Pain in a Patient with Multiple Sclerosis Treated Successfully with Topical Amitriptyline.
Alpha actinin is specifically recognized by multiple sclerosis autoantibodies isolated using an N-glucosylated peptide epitope.
Initial investigation of the blood-brain barrier in MS lesions at 7 tesla.
Clinical outcomes in multiple sclerosis patients following venous angioplasty.
Evaluation of an Online Platform for Multiple Sclerosis Research: Patient Description, Validation of Severity Scale, and Exploration of BMI Effects on Disease Course.
CSF oligoclonal bands are important in the diagnosis of multiple sclerosis, unreasonably downplayed by the McDonald Criteria 2010: No.
TREK-King the Blood-Brain-Barrier.
The insulin-like growth factor system in multiple sclerosis.
Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Characterizing cognitive function during relapse in multiple sclerosis.
Topography of brain sodium accumulation in progressive multiple sclerosis.
Protein kinase Cβ as a therapeutic target stabilizing blood-brain barrier disruption in experimental autoimmune encephalomyelitis.
TLR7 signaling exacerbates CNS autoimmunity through downregulation of Foxp3(+) Treg cells.
Incidence and prevalence of multiple sclerosis in Europe: a systematic review.
Vitamin D receptor biochemical and genetic profiling and HLA-class II genotyping among Lebanese with multiple sclerosis - A pilot study.
A new model of cuprizone-mediated demyelination/remyelination.

Pages